PitchSend

Valo SPAC Presentation Deck

Valo's Opal platform is designed to enable a fully integrated, human-centric approach to the systematic development of better drugs, faster CLINICAL DEVELOPMENT Valo Reg Comm Phase III BIOLOGICAL DISCOVERY Target Discovery RWE Diagnosis Opal PLATFORM Phase II Phase I Preclinical Target ID Target to Hit Lead Opt Hit to Lead THERAPEUTIC DESIGN Comprehensive human-centric data Al-anchored compute Single integrated architecture Valo is building an end-to-end, fully-integrated drug development platform with a unified architecture, founded upon world-class human-centric data and Al-anchored computation 2Q21 12

View entire presentation